Skip to main content

AI-Aided Stethoscope May Aid Home Monitoring of Asthma Exacerbations

Medically reviewed by Carmen Pope, BPharm. Last updated on Dec 8, 2023.

By Lori Solomon HealthDay Reporter

FRIDAY, Dec. 8, 2023 -- An artificial intelligence (AI)-aided home stethoscope provides reliable information on asthma exacerbations, according to a study published in the November/December issue of the Annals of Family Medicine.

Andrzej Emeryk, M.D., Ph.D., from the Medical University of Lublin in Poland, and colleagues evaluated home monitoring of asthma exacerbations with the use of an AI-aided stethoscope. The analysis included 149 patients with asthma (90 children and 59 adults).

The researchers found that the best single-parameter discriminators of exacerbations were wheeze intensity for young children (area under the receiver operating characteristic curve [AUC], 84 percent), rhonchi intensity for older children (AUC, 81 percent), and survey answers for adults (AUC, 92 percent). The greatest efficacy was seen with a combination of several parameters.

"The AI-aided home stethoscope provides reliable information on asthma exacerbations. The parameters provided are effective for children, especially those younger than 5 years of age," the authors write. "The introduction of this tool to the health care system might enhance asthma exacerbation detection substantially and make remote monitoring of patients easier."

Several authors are employees of StethoMe Sp. z o.o., maker of the device used in the study.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Read this next

Higher COVID-19 Vaccination Rates Tied to Decrease in Childhood Asthma Symptoms

WEDNESDAY, July 3, 2024 -- Higher COVID-19 vaccination rates are associated with a lower prevalence of parent-reported childhood asthma symptoms, according to a research letter...

AI-Assisted Contours Superior to Cognitively Defined Prostate Cancer Contours

WEDNESDAY, July 3, 2024 -- Artificial intelligence (AI)-assisted definition of prostate cancer contours reduces underestimation of the extent of prostate cancer, according to a...

Mean Cost of Bringing New Drug to U.S. Market Is $879.3 Million

TUESDAY, July 2, 2024 -- The mean cost of developing a new drug for the U.S. market is estimated to be $879.3 million when both drug development failure and capital costs are...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.